(VRDN) Viridian Therapeutics - Performance -8.5% in 12m
Compare VRDN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
15.42%
#23 in Group
Rel. Strength
35.81%
#5108 in Universe
Total Return 12m
-8.51%
#54 in Group
Total Return 5y
32.89%
#27 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -24.57%
(?) Percentile in Group
12m Total Return: VRDN (-8.5%) vs XBI (-11.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: VRDN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRDN
| Total Return (including Dividends) | VRDN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.35% | 3.80% | 8.14% |
| 3 Months | -24.90% | -11.69% | -3.09% |
| 12 Months | -8.51% | -11.47% | 13.34% |
| 5 Years | 32.89% | -19.52% | 120.03% |
| Trend Score (consistency of price movement) | VRDN | XBI | S&P 500 |
| 1 Month | -11.2% | 48.1% | 90.1% |
| 3 Months | -81.0% | -81% | -66.3% |
| 12 Months | 11.2% | -54.5% | 48.9% |
| 5 Years | 13.9% | -53.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #101 | -4.97% | -8.78% |
| 3 Month | #142 | -15.0% | -22.5% |
| 12 Month | #54 | 3.35% | -19.3% |
| 5 Years | #28 | 65.1% | -39.6% |
FAQs
Does VRDN Viridian Therapeutics outperforms the market?
Yes,
over the last 12 months VRDN made -8.51%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months VRDN made -24.90%, while XBI made -11.69%.
Over the last 3 months VRDN made -24.90%, while XBI made -11.69%.
Performance Comparison VRDN vs Indeces and Sectors
VRDN vs. Indices VRDN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.46% | -9.49% | -39.8% | -21.9% |
| US NASDAQ 100 | QQQ | -4.51% | -12.4% | -40.8% | -23.8% |
| US Dow Jones Industrial 30 | DIA | -2.90% | -6.04% | -38.8% | -17.8% |
| German DAX 40 | DAX | -0.91% | -13.6% | -65.0% | -33.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.92% | -7.08% | -39.7% | -17.5% |
| Hongkong Hang Seng | HSI | -5.05% | -15.7% | -50.8% | -18.9% |
| India NIFTY 50 | INDA | - | -7.80% | -43.2% | -14.3% |
| Brasil Bovespa | EWZ | -2.92% | -11.3% | -45.4% | -2.0% |
VRDN vs. Sectors VRDN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.59% | -9.32% | -44.2% | -31.4% |
| Consumer Discretionary | XLY | -6.61% | -13.0% | -40.1% | -29.0% |
| Consumer Staples | XLP | 0.56% | -0.51% | -43.3% | -15.9% |
| Energy | XLE | -5.07% | -8.18% | -33.2% | -1.86% |
| Financial | XLF | -2.89% | -9.24% | -44.6% | -32.5% |
| Health Care | XLV | 1.58% | 0.51% | -34.6% | -4.82% |
| Industrial | XLI | -4.20% | -11.8% | -41.1% | -22.3% |
| Materials | XLB | -2.63% | -7.55% | -36.0% | -4.60% |
| Real Estate | XLRE | 0.55% | -6.05% | -40.1% | -22.2% |
| Technology | XLK | -5.68% | -15.1% | -38.3% | -19.5% |
| Utilities | XLU | -0.26% | -4.01% | -44.7% | -23.8% |
| Aerospace & Defense | XAR | -1.91% | -11.3% | -48.5% | -36.5% |
| Biotech | XBI | 3.87% | -5.15% | -20.6% | 2.96% |
| Homebuilder | XHB | -4.42% | -11.2% | -28.8% | -3.87% |
| Retail | XRT | -6.15% | -13.1% | -36.1% | -7.81% |